Eric L. Campbell

Eric L. Campbell

Auto-generated profile, based on publicly available information

Eric L. Campbell

Centre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Cell Host & Microbe
Verified
Journal Article
Closed access
CKCaleb J. Kelly
Caleb J. Kelly
LZLeon Zheng
Leon Zheng
ECEric L. Campbell
Eric L. Campbell
BSBejan Saeedi
Bejan Saeedi
CSCarsten C. Scholz
Carsten C. Scholz
SCSean Colgan
Sean Colgan

1 May 2018 in The American Journal of Pathology
Verified
Journal Article
Closed access
EAErica E. Alexeev
Erica E. Alexeev
JLJordi M. Lanis
Jordi M. Lanis
DKDaniel J. Kao
Daniel J. Kao
ECEric L. Campbell
Eric L. Campbell
CKCaleb J. Kelly
Caleb J. Kelly
SCSean Colgan
Sean Colgan

17 September 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ECEric T. Clambey
Eric T. Clambey
EMEóin N. McNamee
Eóin N. McNamee
JWJoseph A. Westrich
Joseph A. Westrich
LGLouise E. Glover
Louise E. Glover
ECEric L. Campbell
Eric L. Campbell
HEHolger K. Eltzschig
Holger K. Eltzschig
Recent studies have demonstrated dramatic shifts in metabolic supply-and-demand ratios during inflammation, a process resulting in localized tissue hypoxia within inflammatory lesions (“inflammatory hypoxia”). As part of the adaptive immune response, T cells are recruited to sites of inflammatory hypoxia. Given the profound effects of hypoxia on gene regulation, we hypothesized that T-cell differentiation is controlled by hypoxia. To pursue this hypothesis, we analyzed the transcriptional consequences of ambient hypoxia (1% oxygen) on a broad panel of T-cell differentiation factors. Surprisingly, these studies revealed selective, robust induction of FoxP3, a key transcriptional regulator for regulatory T cells (Tregs). Studies of promoter binding or loss- and gain-of-function implicated hypoxia-inducible factor (HIF)-1α in inducing FoxP3. Similarly, hypoxia enhanced Treg abundance in vitro and in vivo. Finally, Treg-intrinsic HIF-1α was required for optimal Treg function and Hif1a –deficient Tregs failed to control T-cell–mediated colitis. These studies demonstrate that hypoxia is an intrinsic molecular cue that promotes FoxP3 expression, in turn eliciting potent anti-inflammatory mechanisms to limit tissue damage in conditions of reduced oxygen availability.

1 March 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YSYee-Ping Sun
Yee-Ping Sun
SOSungwhan F. Oh
Sungwhan F. Oh
JUJasim Uddin
Jasim Uddin
RYRong Yang
Rong Yang
KGKatherine Gotlinger
Katherine Gotlinger
CSCharles Serhan
Charles Serhan
We recently uncovered two new families of potent docosahexaenoic acid-derived mediators, termed D series resolvins (Rv; resolution phase interaction products) and protectins. Here, we assign the stereochemistry of the conjugated double bonds and chirality of alcohols present in resolvin D1 (RvD1) and its aspirin-triggered 17R epimer (AT-RvD1) with compounds prepared by total organic synthesis. In addition, docosahexaenoic acid was converted by a single lipoxygenase in a “one-pot” reaction to RvD1 in vitro. The synthetic compounds matched the physical and biological properties of those enzymatically generated. RvD1 proved to be 7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid, AT-RvD1 matched 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid, and they both stopped transendothelial migration of human neutrophils (EC50 ∼30 nm). In murine peritonitis in vivo, RvD1 and AT-RvD1 proved equipotent (at nanogram dosages), limiting polymorphonuclear leukocyte infiltration in a dose-dependent fashion. RvD1 was converted by eicosanoid oxidoreductase to novel 8-oxo- and 17-oxo-RvD1 that gave dramatically reduced bioactivity, whereas enzymatic conversion of AT-RvD1 was sharply reduced. These results establish the complete stereochemistry and actions of RvD1 and AT-RvD1 as well as demonstrate the stereoselective basis for their enzymatic inactivation. RvD1 regulates human polymorphonuclear leukocyte transendothelial migration and is anti-inflammatory. When its carbon 17S alcohol is enzymatically converted to 17-oxo-RvD1, it is essentially inactive, whereas the 17R alcohol configuration in its aspirin-triggered form (AT-RvD1) resists rapid inactivation. These results may contribute to the beneficial actions of aspirin and ω-3 fish oils in humans.

1 January 2014 in Immunity
Verified
Journal Article
Closed access
ECEric L. Campbell
Eric L. Campbell
WBWalter J. Bruyninckx
Walter J. Bruyninckx
CKCaleb J. Kelly
Caleb J. Kelly
LGLouise E. Glover
Louise E. Glover
EMEóin N. McNamee
Eóin N. McNamee
SCSean P. Colgan
Sean P. Colgan

15 April 2010 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
DKDouglas J. Kominsky
Douglas J. Kominsky
ECEric L. Campbell
Eric L. Campbell
SCSean Colgan
Sean Colgan
Sites of ongoing inflammation and triggered immune responses are characterized by significant changes in metabolic activity. Recent studies have indicated that such shifts in tissue metabolism result from a combination of profound recruitment of inflammatory cells (neutrophils and monocytes) and high proliferation rates among lymphocyte populations. The resultant shifts in energy supply and demand can result in metabolic acidosis and diminished delivery and/or availability of oxygen, leading to hypoxia extensive enough to trigger transcriptional and translation changes in tissue phenotype. Such phenotypic shifts can imprint fundamental changes to tissue metabolism. In this study, we review recent work addressing metabolic changes and metabolic control of inflammation and immunity.